Skip to content
OpenCapital
Get started

Boston Scientific BSX Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Abbott logo
AbbottABT
——
Medline, Inc. logo
Medline, Inc. MDLN
——

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$66.81B-37.5%
P/E18.8×-34.0×
P/S3.2×-2.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's business combination, contingent consideration, liability?
Boston Scientific (BSX) reported business combination, contingent consideration, liability of $354M in Q1 2026.
How has Boston Scientific's business combination, contingent consideration, liability changed year-over-year?
Boston Scientific's business combination, contingent consideration, liability increased by 65.4% year-over-year, from $214M to $354M.
What is the long-term trend for Boston Scientific's business combination, contingent consideration, liability?
Over 5 years (2020 to 2025), Boston Scientific's business combination, contingent consideration, liability has grown at a 14.5% compound annual growth rate (CAGR), from $196M to $385M.